Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,463 | 6,706 | 4,717 | 2,691 | 5,007 |
| Receivables | 80 | 60 | 30 | N/A | N/A |
| TOTAL | $4,885 | $6,880 | $4,840 | $2,805 | $5,115 |
| Non-Current Assets | |||||
| PPE Net | 366 | 363 | 339 | 340 | 358 |
| Intangibles | 1,385 | 1,385 | 1,385 | 0 | 0 |
| Other Non-Current Assets | 3,234 | 3,234 | 3,234 | 216 | 316 |
| TOTAL | $4,984 | $4,982 | $4,958 | $556 | $674 |
| Total Assets | $9,869 | $11,862 | $9,798 | $3,362 | $5,789 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 282 | 746 | 467 | 271 | 212 |
| Accrued Expenses | 550 | 340 | 781 | 803 | 765 |
| TOTAL | $873 | $1,136 | $1,308 | $1,118 | $1,021 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 8 | 7 | 6 | N/A | N/A |
| Other Non-Current Liabilities | 782 | 844 | 844 | 0 | 0 |
| TOTAL | $2,035 | $2,097 | $2,097 | $15 | $23 |
| Total Liabilities | $2,908 | $3,233 | $3,405 | $1,134 | $1,043 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,144 | 1,139 | 1,138 | 738 | 643 |
| Common Shares | 6 | 6 | 5 | 3 | 3 |
| Retained earnings | -21,181 | -19,026 | -16,622 | -14,052 | -11,007 |
| TOTAL | $6,961 | $8,629 | $6,393 | $2,228 | $4,746 |
| Total Liabilities And Equity | $9,869 | $11,862 | $9,798 | $3,362 | $5,789 |